Neprhrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case report

Abstract

The pathogenetic role of TNFα in inflammatory diseases has been known for a long time and has modified the therapeutic approach towards this pathology. All over the word, about 400.000 patients have been treated with biological anti-TNFα drugs. Particular attention has been taken for the safety of their use. Let us describe a case of 60 year old man affected by rheumatoid arthritis who has developed nephrotic syndrome with histological pattern typical of systemic lupus erythematosus-like syndrome, without autoantibodies.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Info
Issue
Section
Case Reports
Statistics
  • Abstract views: 863

  • PDF: 605
How to Cite
Portuesi, M., & Perosa, P. (1). Neprhrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case report. Reumatismo, 60(1), 61-63. https://doi.org/10.4081/reumatismo.2008.61